StreetAlpha.app
Home › Stocks › NVS

Novartis AG (NVS)

Healthcare
$150.47
▼ −0.50%
LAST CLOSE · NOV 20

Novartis develops and sells prescription medicines for heart, immune, nerve and cancer conditions. It last closed at $150.47 on Nov 20, down 0.50% on the day.

AI Auto Pilots
Is NVS in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold NVS.

Key Stats

Last 12 months
Results
Net income
$14.0B
+17.1% vs a year ago
Free cash flow
$17.6B
Balance sheet
Cash & equivalents
$11.4B
At Dec 31
Debt
$28.7B
At Dec 31
Shareholder equity
$46.5B
CEOVasant Narasimhan
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $24.0B$24.0BFY2021FY2022: $7.0B$7.0BFY2022FY2023: $14.8B$14.8BFY2023FY2024: $11.9B$11.9BFY2024FY2025: $14.0B$14.0BFY2025

From NVS's SEC filings, latest 20-F for the period ending Dec 31, 2025 (filed Feb 4). Last 12 months adds up the four latest quarters. Per share figures are left out because the US listing can represent a different number of shares.

Next report
—
No date on the calendar yet
Consensus EPS forecast
EPS and revenue estimates
Year-ago EPS
Same quarter last year
Options-implied move
Move priced in by options
Analyst consensus
Ratings from the last 90 days
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on NVS
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on NVS

Technical Analysis

NVS · as of the Nov 20 close · updated each morning
Turning down, nearing oversold

The stock sits between its 20 and 50 day averages. It is 1% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 39), near oversold. The nearest support is the 50 day average at $150.46, and the nearest resistance the Pivot at $151.13.

Short trendBearish
Long trendNeutral
MomentumWeak
StretchNear oversold
VolatilityNormal, 2.1%/day
Key levels
$170.4652 week high+13.3%
$159.1620 day average+5.8%
$154.71Swing high (Jun 11)+2.8%
$152.67200 day average+1.5%
$152.30100 day average+1.2%
$152.03Pivot R1+1.0%
$151.13Pivot+0.4%
$150.47Last close
$150.4650 day average−0.0%
$149.57Pivot S1−0.6%
$149.33Swing low (Jul 20)−0.8%
$123.2452 week low−18.1%
Indicators
RSI (14)38.52Weak, oversold below 30Neutral
MACD0.76Below its signal lineBearish
Stochastic2.8Near the bottom of its rangeOversold
ADX (14)22.1Weak trend
Williams %R-98.5Oversold below −80, overbought above −20Oversold
CCI (20)-172.1Oversold below −100, overbought above 100Oversold
Rate of change−7.4%Change over 10 sessionsBearish
ATR (14)$3.13Typical daily range, 2.1% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Below
MA 200Below
What happened before, for NVS

What happened before

See how NVS did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow NVS usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How NVS has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2005.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for NVSHow many large options trades hit NVS, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

NVS Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bearish
Strongly bearishNeutralStrongly bullish
  • ▼560 buying vs 756 selling
  • ▼Shares held by funds -1.0%
  • ▼Funds holding -66
  • ●Superinvestors: 2 added, 2 cut
  • ▲Put/call 4.18 to 2.95
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holding
Q3 2026This quarterLast quarterChange
Funds holding1,5621,628−4.1%
In funds' top 1010100.0%
Held by funds–––
New / increased92 / 468109 / 519−10.8%
Reduced / sold out615 / 141559 / 90+16.5%
Put/call ratio2.954.18−29.4%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See NVS institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether NVS is in one of them and how their past NVS trades turned out.

NVS in the AI portfolios
Loading…

NVS News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered NVS in an article yet. Here's the latest on the wider market.

NVS in the news

NVS Congress Trades

All congress trades →
Trades, 12 months
3
Buys
2
67%
Sells
1
33%
People
2
Last filed Sep 25
Who traded NVS · since 2014
Latest 5 filings of 102
$15K – $50KTraded Aug 27, 2026Filed Sep 25, 2026
$1K – $15KTraded Mar 31, 2026Filed Jul 21, 2026
$15K – $50KTraded Mar 30, 2026Filed Jul 21, 2026
$1K – $15KTraded Oct 31, 2025Filed Nov 21, 2025
$1K – $15KTraded Oct 30, 2025Filed Nov 21, 2025
PersonTypeAmountTradedFiledDelay
Kevin HernR · OKSell$15K – $50KAug 27, 2026Sep 25, 202629 d
Alan ArmstrongR · OKBuy$1K – $15KMar 31, 2026Jul 21, 2026112 d
Alan ArmstrongR · OKBuy$15K – $50KMar 30, 2026Jul 21, 2026113 d
Lisa McClainR · MISell$1K – $15KOct 31, 2025Nov 21, 202521 d
Lisa McClainR · MIBuy$1K – $15KOct 30, 2025Nov 21, 202522 d

From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data

About Novartis AG

Novartis is a pharmaceutical company based in Basel, Switzerland. It develops and sells medicines in four main therapeutic areas: cardiovascular, renal and metabolic conditions, immunology, neuroscience, and oncology. Its main products include Entresto for heart failure, Cosentyx for psoriasis and Kisqali for breast cancer. Its customers include patients and healthcare systems, with the US, China, Germany and Japan as priority markets.

Headquarters
Basel, Switzerland
Founded
1996